Annual Cash & Cash Equivalents
$27.04 M
-$17.83 M-39.73%
31 December 2023
Summary:
Ovid Therapeutics annual cash & cash equivalents is currently $27.04 million, with the most recent change of -$17.83 million (-39.73%) on 31 December 2023. During the last 3 years, it has fallen by -$44.99 million (-62.46%). OVID annual cash & cash equivalents is now -85.60% below its all-time high of $187.80 million, reached on 31 December 2021.OVID Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$15.02 M
-$14.68 M-49.43%
30 September 2024
Summary:
Ovid Therapeutics quarterly cash and cash equivalents is currently $15.02 million, with the most recent change of -$14.68 million (-49.43%) on 30 September 2024. Over the past year, it has dropped by -$42.42 million (-73.85%). OVID quarterly cash and cash equivalents is now -93.56% below its all-time high of $233.05 million, reached on 31 March 2021.OVID Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OVID Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -39.7% | -73.8% |
| 3 y3 years | -62.5% | -92.6% |
| 5 y5 years | -25.9% | -60.4% |
OVID Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -85.6% | at low | -92.6% | at low |
| 5 y | 5 years | -85.6% | at low | -93.6% | at low |
| alltime | all time | -85.6% | at low | -93.6% | at low |
Ovid Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $15.02 M(-49.4%) |
| June 2024 | - | $29.69 M(-3.5%) |
| Mar 2024 | - | $30.77 M(+13.8%) |
| Dec 2023 | $27.04 M(-39.7%) | $27.04 M(-52.9%) |
| Sept 2023 | - | $57.44 M(-19.8%) |
| June 2023 | - | $71.62 M(+13.6%) |
| Mar 2023 | - | $63.05 M(+40.5%) |
| Dec 2022 | $44.87 M(-76.1%) | $44.87 M(-23.0%) |
| Sept 2022 | - | $58.26 M(-20.0%) |
| June 2022 | - | $72.81 M(-56.3%) |
| Mar 2022 | - | $166.67 M(-11.3%) |
| Dec 2021 | $187.80 M(+160.7%) | $187.80 M(-6.9%) |
| Sept 2021 | - | $201.78 M(-4.9%) |
| June 2021 | - | $212.17 M(-9.0%) |
| Mar 2021 | - | $233.05 M(+223.5%) |
| Dec 2020 | $72.03 M | $72.03 M(-17.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $86.87 M(+110.6%) |
| June 2020 | - | $41.25 M(+50.9%) |
| Mar 2020 | - | $27.34 M(-34.8%) |
| Dec 2019 | $41.90 M(+14.8%) | $41.90 M(+10.5%) |
| Sept 2019 | - | $37.91 M(-20.0%) |
| June 2019 | - | $47.36 M(-13.3%) |
| Mar 2019 | - | $54.60 M(+49.6%) |
| Dec 2018 | $36.49 M(-58.1%) | $36.49 M(+19.6%) |
| Sept 2018 | - | $30.51 M(+35.4%) |
| June 2018 | - | $22.54 M(-22.8%) |
| Mar 2018 | - | $29.20 M(-66.5%) |
| Dec 2017 | $87.13 M(+67.7%) | $87.13 M(-9.3%) |
| Sept 2017 | - | $96.04 M(-9.5%) |
| June 2017 | - | $106.12 M(+139.9%) |
| Mar 2017 | - | $44.23 M(-14.9%) |
| Dec 2016 | $51.94 M(-25.7%) | $51.94 M |
| Dec 2015 | $69.94 M | - |
FAQ
- What is Ovid Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Ovid Therapeutics?
- What is Ovid Therapeutics annual cash & cash equivalents year-on-year change?
- What is Ovid Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Ovid Therapeutics?
- What is Ovid Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Ovid Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of OVID is $27.04 M
What is the all time high annual cash & cash equivalents for Ovid Therapeutics?
Ovid Therapeutics all-time high annual cash & cash equivalents is $187.80 M
What is Ovid Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, OVID annual cash & cash equivalents has changed by -$17.83 M (-39.73%)
What is Ovid Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of OVID is $15.02 M
What is the all time high quarterly cash and cash equivalents for Ovid Therapeutics?
Ovid Therapeutics all-time high quarterly cash and cash equivalents is $233.05 M
What is Ovid Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, OVID quarterly cash and cash equivalents has changed by -$42.42 M (-73.85%)